Neurocrine Biosciences Appoints Andrew Ratz, Ph.D., as Chief Technical Operations Officer

SAN DIEGO, March 17, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the promotion of Andrew Ratz, Ph.D., to the executive management team as the Chief Technical Operations Officer.